Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Do ACE inhibitors improve outcome in patients with stable vascular disease?

Nature Clinical Practice Cardiovascular Medicine volume 4, pages 124–125 (2007)Cite this article

Access through your institution
Buy or subscribe

boxed-textDagenais GR et al. (2006) Angiotensinconverting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials. Lancet 368: 581–588

Background

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Yusuf S et al. (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342: 145–153

    Article  CAS  Google Scholar 

  2. Fox KM ; EUROPA Investigators (2003) Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 362: 782–788

    Article  CAS  Google Scholar 

  3. Braunwald E et al. (2004) Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med 351: 2058–2068

    Article  CAS  Google Scholar 

  4. Al-Mallah MH et al. (2006) Angiotensin-converting enzyme inhibitors in coronary artery disease and preserved left ventricular systolic function: a systematic review and meta-analysis of randomized controlled trials. J Am Coll Cardiol 47: 1576–1583

    Article  CAS  Google Scholar 

  5. Higgins JP et al. (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557–560

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Alexandra King, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. L Køber and C Torp-Pedersen are Professors of Internal Medicine and Consultant Cardiologists at the University of Copenhagen, Denmark.,

    Lars Køber & Christian Torp-Pedersen

Authors
  1. Lars Køber
    View author publications

    Search author on:PubMed Google Scholar

  2. Christian Torp-Pedersen
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Christian Torp-Pedersen.

Ethics declarations

Competing interests

Christian Torp-Pedersen was a steering committee member of the TRACE study, an investigator on the CHARM study, and has given numerous lectures at meetings and symposia sponsored by the industry.

Lars Køber was a steering committee member of the TRACE and VALIANT studies and has also given numerous lectures at meetings and symposia sponsored by the industry.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Køber, L., Torp-Pedersen, C. Do ACE inhibitors improve outcome in patients with stable vascular disease?. Nat Rev Cardiol 4, 124–125 (2007). https://doi.org/10.1038/ncpcardio0776

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0776

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing